Allogene Therapeutics Inc (ALLO)
2.215
+0.10
(+4.98%)
USD |
NASDAQ |
Nov 22, 12:14
Allogene Therapeutics Shareholders Equity (Quarterly): 463.75M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 463.75M |
| June 30, 2024 | 515.04M |
| March 31, 2024 | 461.37M |
| December 31, 2023 | 512.23M |
| September 30, 2023 | 583.10M |
| June 30, 2023 | 622.91M |
| March 31, 2023 | 592.26M |
| December 31, 2022 | 666.88M |
| September 30, 2022 | 739.96M |
| June 30, 2022 | 801.95M |
| March 31, 2022 | 855.23M |
| December 31, 2021 | 925.20M |
| September 30, 2021 | 969.94M |
| Date | Value |
|---|---|
| June 30, 2021 | 1.024B |
| March 31, 2021 | 1.070B |
| December 31, 2020 | 1.080B |
| September 30, 2020 | 1.119B |
| June 30, 2020 | 1.163B |
| March 31, 2020 | 606.52M |
| December 31, 2019 | 629.02M |
| September 30, 2019 | 619.72M |
| June 30, 2019 | 655.64M |
| March 31, 2019 | 681.23M |
| December 31, 2018 | 703.16M |
| September 30, 2018 | -168.44M |
| June 30, 2018 | 281.61M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
461.37M
Minimum
Mar 2024
1.163B
Maximum
Jun 2020
770.04M
Average
703.42M
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals Inc | 430.80M |
| AIM ImmunoTech Inc | 2.912M |
| Perspective Therapeutics Inc | 328.47M |
| Protalix BioTherapeutics Inc | 32.44M |
| Armata Pharmaceuticals Inc | -50.97M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 589.12M |
| Total Liabilities (Quarterly) | 125.37M |